These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1284140)

  • 1. What is the clinical significance of insulin resistance?
    Rett K; Wicklmayr M; Mehnert H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S22-6. PubMed ID: 1284140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
    Ivy JL
    Sports Med; 1997 Nov; 24(5):321-36. PubMed ID: 9368278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of insulin resistance and hyperinsulinemia in coronary heart disease.
    Reaven GM
    Metabolism; 1992 May; 41(5 Suppl 1):16-9. PubMed ID: 1574008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia--how innocent a bystander?
    Zimmet PZ
    Diabetes Care; 1993 Dec; 16 Suppl 3():56-70. PubMed ID: 8299479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease.
    Reaven GM
    Diabete Metab; 1991 May; 17(1 Pt 2):78-86. PubMed ID: 1936488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible synergistic effect of ACE inhibition and calcium-channel blockade on insulin sensitivity in insulin-resistant type II diabetic hypertensive patients.
    Rett K; Jacob S; Wicklmayr M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S29-33. PubMed ID: 7519694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banting lecture 1988. Role of insulin resistance in human disease.
    Reaven GM
    Diabetes; 1988 Dec; 37(12):1595-607. PubMed ID: 3056758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Westernisation, insulin resistance and diabetes in Australian aborigines.
    O'Dea K
    Med J Aust; 1991 Aug; 155(4):258-64. PubMed ID: 1875844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in skeletal muscles in patients with NIDDM.
    Beck-Nielsen H; Vaag A; Damsbo P; Handberg A; Nielsen OH; Henriksen JE; Thye-Rønn P
    Diabetes Care; 1992 Mar; 15(3):418-29. PubMed ID: 1559409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
    Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of insulin resistance in hypertension.
    Rett K; Wicklmayr M; Mehnert H
    Eur Heart J; 1994 Aug; 15 Suppl C():78-81. PubMed ID: 7995275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Lancet; 1989 Jun; 1(8651):1356-9. PubMed ID: 2567374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic agents for the treatment of NIDDM.
    Kuehnle HF
    Exp Clin Endocrinol Diabetes; 1996; 104(2):93-101. PubMed ID: 8740931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.